Root

Kosningar

Forsetakosningar 2024

Dagskrá sjónvarps

Dagskrá útvarps

Auðskilið

Fréttir á auðskildu máli

Ríkisútvarpið

Um RÚV

Íþróttir

Menning og dægurmál

Forsíða

Innlendar fréttir

Erlendar fréttir

Kveikur

Fréttir

Hildur Margrét Jóhannsdóttir

epa08838730 (FILE) - A Russian medical worker displays a trial vaccine against COVID-19 in a post-registration phase of the test at outpatient hospital number 68 in Moscow, Russia, 17 September 2020. Russia registered the new vaccine called 'Sputnik V' against Coronavirus Sars-Cov-2 and opened the stage of its massive testing (reissued 24 November 2020). The Gamaleya National Center of Epidemiology and Microbiology, based in Moscow, said 24 November 2020 their 'second interim analysis of clinical trial data showed a 91.4 per cent efficacy for the Sputnik V vaccine on day 28 after the first dose; vaccine efficacy is over 95 per cent 42 days after the first dose 24 November 2020'.  EPA-EFE/SERGEI ILNITSKY

(FILE) RUSSIA PANDEMIC CORONAVIRUS COVID19 VACCINE

Satt og ósatt um COVID-19

Heilbrigðismál

Um Ríkisútvarpið

Dreifikerfi RÚV

Mannauður

Persónuvernd

Vefkökustillingar

Framleiðsla og efni

Aðgengi

RÚV English

RÚV Polski

Hlaðvarp

Rás 1

Rás 2

Mitt RÚV

RÚV Orð

Hafa samband

Auglýsingar

Dánarfregnir

Fréttir af RÚV

Stefna og starfsemi

RÚV öpp fyrir snjalltæki

Safn RÚV

Skil á efni til RÚV

About RÚV

RÚV Archive